Discovery of a Series of Orally Bioavailable Androgen Receptor Degraders for the Treatment of Prostate Cancer. - Bagal SK; Astles PC; Diène C; Argyrou A; Crafter C; Cassar DJ; Fallan C; Hock A; Jones T; Moreau K; Lamont GM; Lamont S; et al. (Journal of medicinal chemistry, 2024)